Review of the innate immune response in acne vulgaris: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses

Dermatology

Volumn 211, Issue 3, 2005, Pages 193-198

  Kim, Jenny ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acne, inflammatory cytokine responses; Innate immunity; Monocytes macrophages; Toll like receptors

Indexed keywords

ANTIBODY; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2;

ACNE VULGARIS; BACTERIAL VIRULENCE; CELL SURFACE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MONOCYTE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEBACEOUS GLAND DISEASE; WILD TYPE;

ACNE VULGARIS; ANIMALS; AWARDS AND PRIZES; CELLS, CULTURED; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, KNOCKOUT; MONOCYTES; NF-KAPPA B; PROPIONIBACTERIUM ACNES; TOLL-LIKE RECEPTOR 2;

EID: 26244455583     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087011     Document Type: Review

References (35)

1. Guy R, Kealey T: Modelling the infundibulum in acne. Dermatology 1998;196:32-37.
2. Norris JF, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1998;118:651-659.
3. Leyden JJ, McGinley KJ, Mills OH, Kligman AM: Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:382-384.
4. Gilchrist TC: The etiology of acne vulgaris. J Cutan Dis Syphilis 1903;21:107-120.
5. Leyden JJ, McGinley KJ, Vowels BR: P. acnes colonization in acne and nonacne. Dermatology 1998;196:55-58.
6. Oberemok SS, Shalita AR: Acne vulgaris. I. Pathogenesis and diagnosis. Cutis 2002;70:101-105.
7. Kamisango K, Saiki I, Tanio Y, Okumura H, Araki Y, Sekikawa I, Azuma I, Yamamura Y: Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. J Biochem (Tokyo) 1982;92:23-33.
8. Vowels BR, Yang S, Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect Immun 1995;63:3158-3165.
9. Hoeffler U: Enzymatic and hemolytic properties of Propionibacterium acnes and related bacteria. J Clin Microbiol 1977;6:555-558.
10. Hoeffler U, Ko HL, Pulverer G: Antimicrobiol susceptibility of Propionibacterium acnes and related microbial species. Antimicrob Agents Chemother 1976;10:387-394.
11. Ingham E, Holland KT, Gowland G, Cunliffe WJ: Purification and partial characterization of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes. J Gen Microbiol 1980;118:59-65.
12. Puhvel SM, Reisner RM: The production of hyaluronidase (hyaluronate lyase) by Corynebacterium acnes. J Invest Dermatol 1972;58:66-70.
13. Medzhitov R, Preston-Hurlburt P, Janeway CAJ: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
14. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998;395:284-288.
15. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002;416:750-756.
16. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
17. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, Rao G, Sun R, Haberland M, Modlin R, Cheng G: IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002;17:251-263.
18. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998;282:2085-2088.
19. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999;163:1-5.
20. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-1103.
21. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
22. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
23. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999;285:732-736.
24. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771.
25. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL: Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169:1535-1541.
26. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S: Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001;13:933-940.
27. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Role of TLR1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10-14.
28. Webster GF, Leyden JJ, Tsai CC, Baehni P, McArthur WP: Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol 1980;74:398-401.
29. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA: Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-1996.
30. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HA: Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA 1997;94:599-603.
31. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegard G, Keystone EC, Gronberg A: Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-367.
32. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-832.
33. Via CS, Rus V, Gately MK, Finkelman FD: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol 1994;153:4040-4047.
34. Williamson E, Garside P, Bradley JA, Mowat AM: IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol 1996;157:689-699.
35. Nishimura T, Sadata A, Yahagi C, Santa K, Otsuki K, Watanabe K, Yahata T, Habu S: The therapeutic effect of interleukin-12 or its antagonist in transplantation immunity. Ann NY Acad Sci 1996;795:371-374.